Tech Company Financing Transactions
i2O Therapeutics Funding Round
i2O Therapeutics, based in Allston, secured $4 million from JDRF T1D Fund, Sanofi-Genzyme BioVentures and private investors.
Transaction Overview
Company Name
Announced On
4/10/2020
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Seed
Investors
JDRF T1D Fund (Lead Investor) (Katie Ellias)
Sanofi-Genzyme BioVentures (Lead Investor) (Christopher Gagliardi)
Proceeds Purpose
This round of financing will enable us to rapidly expand our team and ramp up research and development at i2O as we seek to create the next generation of oral peptide and protein-based therapies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
127 Western Ave.
Allston, MA 02134
USA
Allston, MA 02134
USA
Phone
Undisclosed
Website
Email Address
Overview
i2o Therapeutics is a biotech company developing safe and effective oral formulations of therapies traditionally limited to injections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Samir Mitragotri
Browse more venture capital transactions:
Prev: 4/10/2020: Bugcrowd venture capital transaction
Next: 4/10/2020: Cohesity venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs